Danielle Smith
Berman Tabacco
- Address of record
- 425 California St. #2300, San Francisco, CA 94104, 415-291-2329
- Phone
- (415) 291-2329
Contact details as filed with the court in the cases below.
Case history
Publicly tracked matters where this attorney is listed as counsel.
FibroGen, Inc. Securities Litigation Settlement
FibroGen and its executives allegedly misrepresented the safety profile and Phase III trial results of its anti-anemia drug Roxadustat in filings with the FDA. Investors claim the company's stock price was artificially inflated by these false statements and declined when the truth was revealed. The defendants deny all allegations of wrongdoing.
- Settlement fund
- $28.5M
- Claim deadline
- Represents
- Vicente Sepulveda
Plantronics Securities Litigation Settlement
Plantronics and several of its senior officers allegedly made false and misleading statements regarding the company's sales practices in violation of federal securities laws. The defendants deny any wrongdoing or liability. The parties have settled for $29.5 million.
- Settlement fund
- $29.5M
- Claim deadline
- June 25, 2025
- Represents
- Ilya Trubnikov
“Recovery” and “exposure” refer to total disclosed settlement funds in associated cases, not money personally won or lost by an attorney. Settlements generally resolve disputed allegations without a finding that either side won. Data comes from public court dockets and may be incomplete.